List

Design and field test system, at interested DOT sites, research commercialization market, seek pre-orders from State, Federal, Tribal and local Government entities for full production phase.

The US is targeting the goal of 36 billion gallons of liquid transportation biofuels by 2022. Currently we produce approximately 10 billion gallons of ethanol from corn starch. In order to produce the remaining 26 billion gallons of liquid biofuels from cellulosic sources two major problems need to be solved, the logistics of crop production and the million tons of enzymes necessary to deconstruct ...

Consumption of milk and dairy products is one of the best, and most available, sources of nutrition in the world. Unfortunately, one of the most common sources of foodborne illness is contaminated milk. This is especially true in third world countries where sanitation practices are primitive and refrigeration on-farm or during transport to milk processing plants is very unreliable due to instabili ...

(23) Non-technical Summary: TITLE: Plant Produced Porcine Il-12 Vaccine Adjuvant for Swine Flu and Other Viral Diseases PD: Radin, David N., PhD, BioStrategies LC CoPD: Cramer, Carole L., PhD, Arkansas State University and BioStrategies LC CoPD: Medrano, Giuliana, PhD, Arkansas State University As the nation attempts to meet the challenges posed by the spread of pandemic influenza there is a need ...

This project develops a nutrition program, MenuChoice©, for community-based group homes for persons with intellectual or developmental disabilities (IDD). Adults with IDD experience poorer nutritional health and more nutrition-related secondary conditions than adults without disabilities. These conditions are preventable and modifiable through a safe, healthful diet, but multiple challenges precl ...

DESCRIPTION (provided by applicant): The purpose of the proposal is to develop medical device coatings that bind and release therapeutic proteins, particularly growth factors. Specifically, we propose to systematically optimize and control growth factor binding and release using protocols that can be translated to the operating room. Bone fracture repair and reconstruction of critical-sized defect ...

DESCRIPTION (provided by applicant): This Phase 1 NIH SBIR proposal is for support of an interdisciplinary program involving the Oasis Diagnostics(R) Corporation, Madison Biodiagnostics, LLC, and the University of New Orleans who seek to collaboratively demonstrate an innovative saliva collection and analysis system (VerOFy(R)) for measurement of cortisol levels at the point of sampling for measur ...

DESCRIPTION (provided by applicant): The funding of the application will yield safety and efficacy data on a new combination cancer therapy for leukemia and lymphomas. Monoclonal antibodies (mAbs) have emerged as a class of novel oncology therapeutics. Weare developing a molecule that can improve the therapeutic effects of mAbs by: 1) increasing the sensitivity of cancers to treatment 2) unmaskin ...

DESCRIPTION (provided by applicant): Title: Analgesics Targeting TRPA1 for Treatment of Chronic Pain Abstract An effective treatment for chronic pain that is devoid of both addictive potential and abuse liability is a major unmet need in medicine today. These limitations drive the need for novel treatment options based on new molecular mechanisms. Our goal is to identify and develop a novel, ...

DESCRIPTION (provided by applicant): The objective of this project is to develop a therapeutic strategy for H V-associated malignancy based on the role of HPV in the pathogenesis. HPV related cancers express the E6/E7 oncoproteins of HPV that are ideal targets for immune inducing vaccines. We will develop a vaccine based upon a novel adenovirus serotype-S vector (Ads) platform with unique and addi ...